Wells Fargo’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $24.7M | Buy |
|
|||||
|
2025
Q2 | $20.8M | Buy |
|
|||||
|
2025
Q1 | $21.1M | Buy |
|
|||||
|
2024
Q4 | $17M | Sell |
|
|||||
|
2024
Q3 | $40M | Sell |
|
|||||
|
2024
Q2 | $57.4M | Buy |
|
|||||
|
2024
Q1 | $47.7M | Sell |
|
|||||
|
2023
Q4 | $59.9M | Buy |
|
|||||
|
2023
Q3 | $55.2M | Sell |
|
|||||
|
2023
Q2 | $71.2M | Sell |
|
|||||
|
2023
Q1 | $70.9M | Sell |
|
|||||
|
2022
Q4 | $73.7M | Sell |
|
|||||
|
2022
Q3 | $85.2M | Sell |
|
|||||
|
2022
Q2 | $73.2M | Sell |
|
|||||
|
2022
Q1 | $92.6M | Buy |
|
|||||
|
2021
Q4 | $96.2M | Sell |
|
|||||
|
2021
Q3 | $162M | Buy |
|
|||||
|
2021
Q2 | $190M | Sell |
|
|||||
|
2021
Q1 | $162M | Sell |
|
|||||
|
2020
Q4 | $147M | Sell |
|
|||||
|
2020
Q3 | $213M | Buy |
|
|||||
|
2020
Q2 | $199M | Buy |
|
|||||
|
2020
Q1 | $222M | Sell |
|
|||||
|
2019
Q4 | $248M | Sell |
|
|||||
|
2019
Q3 | $197M | Sell |
|
|||||
|
2019
Q2 | $199M | Sell |
|
|||||
|
2019
Q1 | $225M | Sell |
|
|||||
|
2018
Q4 | $318M | Buy |
|
|||||
|
2018
Q3 | $355M | Sell |
|
|||||
|
2018
Q2 | $304M | Buy |
|
|||||
|
2018
Q1 | $278M | Sell |
|
|||||
|
2017
Q4 | $367M | Buy |
|
|||||
|
2017
Q3 | $306M | Sell |
|
|||||
|
2017
Q2 | $323M | Buy |
|
|||||
|
2017
Q1 | $313M | Buy |
|
|||||
|
2016
Q4 | $273M | Sell |
|
|||||
|
2016
Q3 | $340M | Buy |
|
|||||
|
2016
Q2 | $260M | Buy |
|
|||||
|
2016
Q1 | $217M | Buy |
|
|||||
|
2015
Q4 | $239M | Sell |
|
|||||
|
2015
Q3 | $374M | Sell |
|
|||||
|
2015
Q2 | $901M | Sell |
|
|||||
|
2015
Q1 | $1.02B | Sell |
|
|||||
|
2014
Q4 | $920M | Buy |
|
|||||
|
2014
Q3 | $891M | Buy |
|
|||||
|
2014
Q2 | $790M | Buy |
|
|||||
|
2014
Q1 | $737M | Buy |
|
|||||
|
2013
Q4 | $597M | Buy |
|
|||||
|
2013
Q3 | $477M | Buy |
|
|||||
|
2013
Q2 | $416M | Buy |
|